Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.2 - $4.98 $102,801 - $232,705
46,728 New
46,728 $106,000
Q4 2022

Feb 14, 2023

BUY
$5.19 - $13.5 $125,001 - $325,147
24,085 New
24,085 $131,000
Q1 2020

Apr 09, 2020

SELL
$9.07 - $26.32 $142,943 - $414,803
-15,760 Closed
0 $0
Q4 2019

Jan 16, 2020

BUY
$20.54 - $31.0 $323,710 - $488,560
15,760 New
15,760 $417,000

Others Institutions Holding GTHX

About G1 Therapeutics, Inc.


  • Ticker GTHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,746,800
  • Market Cap $306M
  • Description
  • G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...
More about GTHX
Track This Portfolio

Track Alpine Global Management, LLC Portfolio

Follow Alpine Global Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Global Management, LLC with notifications on news.